메뉴 건너뛰기




Volumn 14, Issue 1, 2017, Pages 1-13

Regulatory landscape of AGE-RAGE-oxidative stress axis and its modulation by PPARγ activation in high fructose diet-induced metabolic syndrome

Author keywords

AGE RAGE oxidative stress axis; Fructose; HNE; Metabolic syndrome; PPAR ; Rosiglitazone

Indexed keywords

4 HYDROXYNONENAL; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ADVANCED OXIDATION PROTEIN PRODUCT; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE;

EID: 85010297712     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/s12986-016-0149-z     Document Type: Article
Times cited : (33)

References (51)
  • 1
    • 84856410314 scopus 로고    scopus 로고
    • Public health: the toxic truth about sugar
    • 22297952
    • Lustig RH, Schmidt LA, Brindis CD. Public health: the toxic truth about sugar. Nature. 2012;482:27-9.
    • (2012) Nature , vol.482 , pp. 27-29
    • Lustig, R.H.1    Schmidt, L.A.2    Brindis, C.D.3
  • 2
    • 70350245011 scopus 로고    scopus 로고
    • Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity
    • International Diabetes Federation Task Force on E, Prevention Hational Heart L Blood I American Heart A World Heart F International Atherosclerosis S International Association for the Study of O 19805654
    • Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith Jr SC, International Diabetes Federation Task Force on E, Prevention, Hational Heart L, Blood I, American Heart A, World Heart F, International Atherosclerosis S, International Association for the Study of O. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009;120:1640-5.
    • (2009) Circulation , vol.120 , pp. 1640-1645
    • Alberti, K.G.1    Eckel, R.H.2    Grundy, S.M.3    Zimmet, P.Z.4    Cleeman, J.I.5    Donato, K.A.6    Fruchart, J.C.7    James, W.P.8    Loria, C.M.9    Smith, S.C.10
  • 3
    • 0036787485 scopus 로고    scopus 로고
    • Components of the “metabolic syndrome” and incidence of type two diabetes
    • 12351457
    • Hanson RL, Imperatore G, Bennett PH, Knowler WC. Components of the “metabolic syndrome” and incidence of type two diabetes. Diabetes. 2002;51:3120-7.
    • (2002) Diabetes , vol.51 , pp. 3120-3127
    • Hanson, R.L.1    Imperatore, G.2    Bennett, P.H.3    Knowler, W.C.4
  • 4
    • 84864232454 scopus 로고    scopus 로고
    • The relation between fructose-induced metabolic syndrome and altered renal haemodynamic and excretory function in the Rat
    • 21785727 3139200
    • Abdulla MH, Sattar MA, Johns EJ. The relation between fructose-induced metabolic syndrome and altered renal haemodynamic and excretory function in the Rat. Int J Nephrol. 2011;2011:934659.
    • (2011) Int J Nephrol , vol.2011 , pp. 934659
    • Abdulla, M.H.1    Sattar, M.A.2    Johns, E.J.3
  • 5
    • 84929942019 scopus 로고    scopus 로고
    • The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases
    • 25818485
    • Maessen DEM, Stehouwer CDA, Schalkwijk CG. The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases. Clin Sci. 2015;128:839-61.
    • (2015) Clin Sci , vol.128 , pp. 839-861
    • Maessen, D.E.M.1    Stehouwer, C.D.A.2    Schalkwijk, C.G.3
  • 6
    • 0030763201 scopus 로고    scopus 로고
    • Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging
    • 9022079 507819
    • Schleicher ED, Wagner E, Nerlich AG. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest. 1997;99:457-68.
    • (1997) J Clin Invest , vol.99 , pp. 457-468
    • Schleicher, E.D.1    Wagner, E.2    Nerlich, A.G.3
  • 7
    • 0030919275 scopus 로고    scopus 로고
    • N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins
    • 9182719 1218467
    • Ahmed MU, Brinkmann Frye E, Degenhardt TP, Thorpe SR, Baynes JW. N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J. 1997;324(Pt 2):565-70.
    • (1997) Biochem J , vol.324 , pp. 565-570
    • Ahmed, M.U.1    Brinkmann Frye, E.2    Degenhardt, T.P.3    Thorpe, S.R.4    Baynes, J.W.5
  • 10
    • 0031036134 scopus 로고    scopus 로고
    • Vitamin E improves the free radical defense system potential and insulin sensitivity of rats fed high fructose diets
    • 9040552
    • Faure P, Rossini E, Lafond JL, Richard MJ, Favier A, Halimi S. Vitamin E improves the free radical defense system potential and insulin sensitivity of rats fed high fructose diets. J Nutr. 1997;127:103-7.
    • (1997) J Nutr , vol.127 , pp. 103-107
    • Faure, P.1    Rossini, E.2    Lafond, J.L.3    Richard, M.J.4    Favier, A.5    Halimi, S.6
  • 11
    • 38049113001 scopus 로고    scopus 로고
    • Renoprotective action of L-carnitine in fructose-induced metabolic syndrome
    • 18093214
    • Rajasekar P, Viswanathan P, Anuradha CV. Renoprotective action of L-carnitine in fructose-induced metabolic syndrome. Diabetes Obes Metab. 2008;10:171-80.
    • (2008) Diabetes Obes Metab , vol.10 , pp. 171-180
    • Rajasekar, P.1    Viswanathan, P.2    Anuradha, C.V.3
  • 13
    • 77956184900 scopus 로고    scopus 로고
    • Suppression of hepatic oxidative events and regulation of eNOS expression in the liver by naringenin in fructose-administered rats
    • 20655900
    • Kannappan S, Palanisamy N, Anuradha CV. Suppression of hepatic oxidative events and regulation of eNOS expression in the liver by naringenin in fructose-administered rats. Eur J Pharmacol. 2010;645:177-84.
    • (2010) Eur J Pharmacol , vol.645 , pp. 177-184
    • Kannappan, S.1    Palanisamy, N.2    Anuradha, C.V.3
  • 14
    • 84939514709 scopus 로고    scopus 로고
    • SAR and computer-aided drug design approaches in the discovery of peroxisome proliferator-activated receptor γ activators: a perspective
    • Dixit VA, Bharatam PV. SAR and computer-aided drug design approaches in the discovery of peroxisome proliferator-activated receptor γ activators: a perspective. J Computational Med. 2013;2013:38.
    • (2013) J Computational Med , vol.2013 , pp. 38
    • Dixit, V.A.1    Bharatam, P.V.2
  • 15
    • 84869490816 scopus 로고    scopus 로고
    • Pyrrolidinediones reduce the toxicity of thiazolidinediones and modify their anti-diabetic and anti-cancer properties
    • 23041271
    • Saha S, Chan DS, Lee CY, Wong W, New LS, Chui WK, Yap CW, Chan EC, Ho HK. Pyrrolidinediones reduce the toxicity of thiazolidinediones and modify their anti-diabetic and anti-cancer properties. Eur J Pharmacol. 2012;697:13-23.
    • (2012) Eur J Pharmacol , vol.697 , pp. 13-23
    • Saha, S.1    Chan, D.S.2    Lee, C.Y.3    Wong, W.4    New, L.S.5    Chui, W.K.6    Yap, C.W.7    Chan, E.C.8    Ho, H.K.9
  • 16
    • 79952276940 scopus 로고    scopus 로고
    • Thiazolidinedione therapy for managing metabolic syndrome
    • 21166377
    • Geurin MD, St Anna L. Thiazolidinedione therapy for managing metabolic syndrome. Am Fam Physician. 2010;82:1553-4.
    • (2010) Am Fam Physician , vol.82 , pp. 1553-1554
    • Geurin, M.D.1    St Anna, L.2
  • 17
    • 84923116676 scopus 로고    scopus 로고
    • Combined delivery of the adiponectin gene and rosiglitazone using cationic lipid emulsions
    • 25681724
    • Davaa E, Kang BS, Han JH, Lee SE, Ng CL, Myung CS, Park JS. Combined delivery of the adiponectin gene and rosiglitazone using cationic lipid emulsions. Int J Pharm. 2015;483:124-30.
    • (2015) Int J Pharm , vol.483 , pp. 124-130
    • Davaa, E.1    Kang, B.S.2    Han, J.H.3    Lee, S.E.4    Ng, C.L.5    Myung, C.S.6    Park, J.S.7
  • 18
    • 19244365650 scopus 로고    scopus 로고
    • Thiazolidinediones
    • 15356308
    • Yki-Jarvinen H. Thiazolidinediones. N Engl J Med. 2004;351:1106-18.
    • (2004) N Engl J Med , vol.351 , pp. 1106-1118
    • Yki-Jarvinen, H.1
  • 19
    • 12344316682 scopus 로고    scopus 로고
    • Thiazolidinediones: a review of their mechanisms of insulin sensitization, therapeutic potential, clinical efficacy, and tolerability
    • 15684639
    • Vasudevan AR, Balasubramanyam A. Thiazolidinediones: a review of their mechanisms of insulin sensitization, therapeutic potential, clinical efficacy, and tolerability. Diabetes Technol Ther. 2004;6:850-63.
    • (2004) Diabetes Technol Ther , vol.6 , pp. 850-863
    • Vasudevan, A.R.1    Balasubramanyam, A.2
  • 20
    • 84880339801 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor-gamma activators monascin and rosiglitazone attenuate carboxymethyllysine-induced fibrosis in hepatic stellate cells through regulating the oxidative stress pathway but independent of the receptor for advanced glycation end products signaling
    • 23796251
    • Hsu WH, Lee BH, Hsu YW, Pan TM. Peroxisome proliferator-activated receptor-gamma activators monascin and rosiglitazone attenuate carboxymethyllysine-induced fibrosis in hepatic stellate cells through regulating the oxidative stress pathway but independent of the receptor for advanced glycation end products signaling. J Agric Food Chem. 2013;61:6873-9.
    • (2013) J Agric Food Chem , vol.61 , pp. 6873-6879
    • Hsu, W.H.1    Lee, B.H.2    Hsu, Y.W.3    Pan, T.M.4
  • 22
    • 84859428437 scopus 로고    scopus 로고
    • PPAR-gamma agonist rosiglitazone attenuates the inflammation caused by carrageenan in the mouse model of pleurisy
    • Buss ZS, Medeiros YS, Fröde TS. PPAR-gamma agonist rosiglitazone attenuates the inflammation caused by carrageenan in the mouse model of pleurisy. Inflammation. 2012;35:280-8.
    • (2012) Inflammation , vol.35 , pp. 280-288
    • Buss, Z.S.1    Medeiros, Y.S.2    Fröde, T.S.3
  • 23
    • 80051514413 scopus 로고    scopus 로고
    • Rosiglitazone protects neuroblastoma cells against advanced glycation end products-induced injury
    • 21765445 4002533
    • Wang L, Yu CJ, Liu W, Cheng LY, Zhang YN. Rosiglitazone protects neuroblastoma cells against advanced glycation end products-induced injury. Acta Pharmacol Sin. 2011;32:991-8.
    • (2011) Acta Pharmacol Sin , vol.32 , pp. 991-998
    • Wang, L.1    Yu, C.J.2    Liu, W.3    Cheng, L.Y.4    Zhang, Y.N.5
  • 24
    • 71649112618 scopus 로고    scopus 로고
    • Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products
    • 19917066 2807648
    • Liang C, Ren Y, Tan H, He Z, Jiang Q, Wu J, Zhen Y, Fan M, Wu Z. Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products. Br J Pharmacol. 2009;158:1865-73.
    • (2009) Br J Pharmacol , vol.158 , pp. 1865-1873
    • Liang, C.1    Ren, Y.2    Tan, H.3    He, Z.4    Jiang, Q.5    Wu, J.6    Zhen, Y.7    Fan, M.8    Wu, Z.9
  • 25
    • 67349088792 scopus 로고    scopus 로고
    • PPARgamma-mediated advanced glycation end products regulation of neural stem cells
    • 19524138
    • Wang SH, Sun ZL, Guo YJ, Yuan Y, Li L. PPARgamma-mediated advanced glycation end products regulation of neural stem cells. Mol Cell Endocrinol. 2009;307:176-84.
    • (2009) Mol Cell Endocrinol , vol.307 , pp. 176-184
    • Wang, S.H.1    Sun, Z.L.2    Guo, Y.J.3    Yuan, Y.4    Li, L.5
  • 26
    • 84882799486 scopus 로고    scopus 로고
    • Drug treatment of metabolic syndrome
    • 22950955
    • Altabas V. Drug treatment of metabolic syndrome. Curr Clin Pharmacol. 2013;8:224-31.
    • (2013) Curr Clin Pharmacol , vol.8 , pp. 224-231
    • Altabas, V.1
  • 27
    • 84892977814 scopus 로고    scopus 로고
    • Targeting peroxisome proliferator-activated receptor gamma for generation of antidiabetic drug
    • 23746081
    • Karak M, Bal NC, Bal C, Sharon A. Targeting peroxisome proliferator-activated receptor gamma for generation of antidiabetic drug. Curr Diabetes Rev. 2013;9:275-85.
    • (2013) Curr Diabetes Rev , vol.9 , pp. 275-285
    • Karak, M.1    Bal, N.C.2    Bal, C.3    Sharon, A.4
  • 28
    • 84902158832 scopus 로고    scopus 로고
    • In silico identification of potent PPAR-gamma agonists from traditional Chinese medicine: a bioactivity prediction, virtual screening, and molecular dynamics study
    • 24971147 4058246
    • Chen KC, Chen CY. In silico identification of potent PPAR-gamma agonists from traditional Chinese medicine: a bioactivity prediction, virtual screening, and molecular dynamics study. Evid Based Complement Alternat Med. 2014;2014:192452.
    • (2014) Evid Based Complement Alternat Med , vol.2014 , pp. 192452
    • Chen, K.C.1    Chen, C.Y.2
  • 29
    • 84896825651 scopus 로고    scopus 로고
    • New insights into the PPAR gamma agonists for the treatment of diabetic nephropathy
    • 24624137 3927865
    • Jia Z, Sun Y, Yang G, Zhang A, Huang S, Heiney KM, Zhang Y. New insights into the PPAR gamma agonists for the treatment of diabetic nephropathy. PPAR Res. 2014;2014:818530.
    • (2014) PPAR Res , vol.2014 , pp. 818530
    • Jia, Z.1    Sun, Y.2    Yang, G.3    Zhang, A.4    Huang, S.5    Heiney, K.M.6    Zhang, Y.7
  • 30
    • 34250213233 scopus 로고    scopus 로고
    • Evolution of peroxisome proliferator-activated receptor agonists
    • 17519293
    • Chang F, Jaber LA, Berlie HD, O’Connell MB. Evolution of peroxisome proliferator-activated receptor agonists. Ann Pharmacother. 2007;41:973-83.
    • (2007) Ann Pharmacother , vol.41 , pp. 973-983
    • Chang, F.1    Jaber, L.A.2    Berlie, H.D.3    O’Connell, M.B.4
  • 32
    • 85010385750 scopus 로고
    • Blood pressure measurement in rats
    • Elsevier Amsterdam
    • RD B. Blood pressure measurement in rats. In: Handbook of hypertension. Amsterdam: Elsevier; 1994. p. 17.
    • (1994) Handbook of hypertension , pp. 17
    • Rd, B.1
  • 34
    • 18244375243 scopus 로고    scopus 로고
    • Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction
    • 15824194
    • Ackerman Z, Oron-Herman M, Grozovski M, Rosenthal T, Pappo O, Link G, Sela BA. Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction. Hypertension. 2005;45:1012-8.
    • (2005) Hypertension , vol.45 , pp. 1012-1018
    • Ackerman, Z.1    Oron-Herman, M.2    Grozovski, M.3    Rosenthal, T.4    Pappo, O.5    Link, G.6    Sela, B.A.7
  • 36
    • 84964510429 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type two diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis
    • 26667191
    • Ballestri S, Zona S, Targher G, Romagnoli D, Baldelli E, Nascimbeni F, Roverato A, Guaraldi G, Lonardo A. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type two diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis. J Gastroenterol Hepatol. 2016;31:936-44.
    • (2016) J Gastroenterol Hepatol , vol.31 , pp. 936-944
    • Ballestri, S.1    Zona, S.2    Targher, G.3    Romagnoli, D.4    Baldelli, E.5    Nascimbeni, F.6    Roverato, A.7    Guaraldi, G.8    Lonardo, A.9
  • 37
    • 84993675348 scopus 로고    scopus 로고
    • The independent predictors of non-alcoholic steatohepatitis and its individual histological features : Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment
    • Ballestri S, Nascimbeni F, Romagnoli D, Lonardo A. The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment. Hepatol Res. 2016;46:1074-87.
    • (2016) Hepatol Res , vol.46 , pp. 1074-1087
    • Ballestri, S.1    Nascimbeni, F.2    Romagnoli, D.3    Lonardo, A.4
  • 38
    • 84957706228 scopus 로고    scopus 로고
    • Role of dietary fructose and hepatic De novo lipogenesis in fatty liver disease
    • 26856717
    • Softic S, Cohen DE, Kahn CR. Role of dietary fructose and hepatic De novo lipogenesis in fatty liver disease. Dig Dis Sci. 2016;61:1282-93.
    • (2016) Dig Dis Sci , vol.61 , pp. 1282-1293
    • Softic, S.1    Cohen, D.E.2    Kahn, C.R.3
  • 39
    • 84922622191 scopus 로고    scopus 로고
    • A concise review of non-alcoholic fatty liver disease
    • 25617860
    • Than NN, Newsome PN. A concise review of non-alcoholic fatty liver disease. Atherosclerosis. 2015;239:192-202.
    • (2015) Atherosclerosis , vol.239 , pp. 192-202
    • Than, N.N.1    Newsome, P.N.2
  • 40
    • 82155197195 scopus 로고    scopus 로고
    • Kaempferol regulates the lipid-profile in high-fat diet-fed rats through an increase in hepatic PPARalpha levels
    • 21728151
    • Chang CJ, Tzeng TF, Liou SS, Chang YS, Liu IM. Kaempferol regulates the lipid-profile in high-fat diet-fed rats through an increase in hepatic PPARalpha levels. Planta Med. 2011;77:1876-82.
    • (2011) Planta Med , vol.77 , pp. 1876-1882
    • Chang, C.J.1    Tzeng, T.F.2    Liou, S.S.3    Chang, Y.S.4    Liu, I.M.5
  • 42
    • 84939986934 scopus 로고    scopus 로고
    • DHA inhibited AGEs-induced retinal microglia activation via suppression of the PPARgamma/NFkappaB pathway and reduction of signal transducers in the AGEs/RAGE axis recruitment into lipid rafts
    • 25596942
    • Wang L, Chen K, Liu K, Zhou Y, Zhang T, Wang B, Mi M. DHA inhibited AGEs-induced retinal microglia activation via suppression of the PPARgamma/NFkappaB pathway and reduction of signal transducers in the AGEs/RAGE axis recruitment into lipid rafts. Neurochem Res. 2015;40:713-22.
    • (2015) Neurochem Res , vol.40 , pp. 713-722
    • Wang, L.1    Chen, K.2    Liu, K.3    Zhou, Y.4    Zhang, T.5    Wang, B.6    Mi, M.7
  • 46
    • 77954880936 scopus 로고    scopus 로고
    • Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation
    • 20233219 2958635
    • Collino M, Aragno M, Castiglia S, Miglio G, Tomasinelli C, Boccuzzi G, Thiemermann C, Fantozzi R. Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation. Br J Pharmacol. 2010;160:1892-902.
    • (2010) Br J Pharmacol , vol.160 , pp. 1892-1902
    • Collino, M.1    Aragno, M.2    Castiglia, S.3    Miglio, G.4    Tomasinelli, C.5    Boccuzzi, G.6    Thiemermann, C.7    Fantozzi, R.8
  • 47
    • 79955645297 scopus 로고    scopus 로고
    • Losartan and pioglitazone ameliorate nephropathy in experimental metabolic syndrome rats
    • 21532159
    • Kong X, Zhang DY, Wu HB, Li FX. Losartan and pioglitazone ameliorate nephropathy in experimental metabolic syndrome rats. Biol Pharm Bull. 2011;34:693-9.
    • (2011) Biol Pharm Bull , vol.34 , pp. 693-699
    • Kong, X.1    Zhang, D.Y.2    Wu, H.B.3    Li, F.X.4
  • 49
    • 4644271610 scopus 로고    scopus 로고
    • Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification
    • 15343583
    • Schalkwijk CG, Stehouwer CD, van Hinsbergh VW. Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification. Diabetes Metab Res Rev. 2004;20:369-82.
    • (2004) Diabetes Metab Res Rev , vol.20 , pp. 369-382
    • Schalkwijk, C.G.1    Stehouwer, C.D.2    Van Hinsbergh, V.W.3
  • 50
    • 9144219652 scopus 로고    scopus 로고
    • A lipid peroxidation-derived inflammatory mediator: identification of 4-hydroxy-2-nonenal as a potential inducer of cyclooxygenase-2 in macrophages
    • 15355999
    • Kumagai T, Matsukawa N, Kaneko Y, Kusumi Y, Mitsumata M, Uchida K. A lipid peroxidation-derived inflammatory mediator: identification of 4-hydroxy-2-nonenal as a potential inducer of cyclooxygenase-2 in macrophages. J Biol Chem. 2004;279:48389-96.
    • (2004) J Biol Chem , vol.279 , pp. 48389-48396
    • Kumagai, T.1    Matsukawa, N.2    Kaneko, Y.3    Kusumi, Y.4    Mitsumata, M.5    Uchida, K.6
  • 51
    • 0035458292 scopus 로고    scopus 로고
    • Advanced glycation end products in nondiabetic patients with coronary artery disease
    • 11522709
    • Kanauchi M, Tsujimoto N, Hashimoto T. Advanced glycation end products in nondiabetic patients with coronary artery disease. Diabetes Care. 2001;24:1620-3.
    • (2001) Diabetes Care , vol.24 , pp. 1620-1623
    • Kanauchi, M.1    Tsujimoto, N.2    Hashimoto, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.